Trial Profile
Influence of fingolimod on circulating microRNA levels in multiple sclerosis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2014
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic
- 06 Oct 2014 New trial record